Drugs / Siloss®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02639572 | Jan → Aug 2014 | chronic periodontitis | SVS Institute of Dental Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Siloss | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02639572 ↗ |
| Modality | Other / unclassified | “Siloss® (Azurebio, Madrid, Spain) is a synthetic and inorganic bone graft material” NCT02639572 ↗ |